Literature DB >> 8387536

Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.

M G Swain1, V Patchev, J Vergalla, G Chrousos, E A Jones.   

Abstract

Cholestatic patients undergoing surgery have increased mortality and demonstrate clinical features suggestive of adrenal insufficiency. To examine whether cholestasis influences the status of the hypothalamic-pituitary-adrenal axis, we evaluated rats with acute cholestasis caused by bile duct resection (BDR) and sham-operated and unoperated controls. Basal unstressed plasma concentrations of ACTH and corticosterone were similar in BDR and sham-operated and unoperated control rats. However, exposure of BDR rats to saturated ether vapor resulted in significantly less ACTH and corticosterone release in plasma than in the control animals. To understand the mechanism(s) of decreased HPA axis responsiveness to ether stress in cholestasis, we administered corticotropin-releasing factor (CRF) and measured hypothalamic content, mRNA levels and in vitro secretion of CRF and arginine vasopressin (AVP), the two principal secretagogues of ACTH. In BDR animals, ACTH responses to CRF were decreased and hypothalamic content of CRF and CRF mRNA expression in the paraventricular nucleus were decreased by 25 and 37%, respectively. Furthermore, CRF release from hypothalamic explants of BDR rats was 23% less than that of controls. In contrast to CRF, hypothalamic content of AVP was 35% higher, AVP mRNA in the paraventricular nucleus was increased by 6.6-fold, and hypothalamic explant release of AVP was 24% higher in BDR rats than in control animals. Pituitary ACTH contents were similar in BDR and sham resected rats, but higher than unoperated controls. These findings demonstrate that acute cholestasis in the rat is associated with suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress and demonstrate a dissociation between mechanisms of ACTH regulation mediated by CRF and AVP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387536      PMCID: PMC288184          DOI: 10.1172/JCI116408

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Changes in production of interleukin-1 and interleukin-2 associated with obstructive jaundice and biliary drainage in patients with gastrointestinal cancer.

Authors:  Y Haga; K Sakamoto; H Egami; Y Yokoyama; M Arai; K Mori; M Akagi
Journal:  Surgery       Date:  1989-11       Impact factor: 3.982

2.  Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami.

Authors:  A E Calogero; R Bernardini; A N Margioris; G Bagdy; W T Gallucci; P J Munson; L Tamarkin; T P Tomai; L Brady; P W Gold
Journal:  Peptides       Date:  1989 Jan-Feb       Impact factor: 3.750

3.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

4.  Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats.

Authors:  L S Brady; M A Smith; P W Gold; M Herkenham
Journal:  Neuroendocrinology       Date:  1990-11       Impact factor: 4.914

5.  Tumor necrosis factor-alpha is a potent ACTH secretagogue: comparison to interleukin-1 beta.

Authors:  B M Sharp; S G Matta; P K Peterson; R Newton; C Chao; K Mcallen
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

6.  Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality.

Authors:  M A Marano; Y Fong; L L Moldawer; H Wei; S E Calvano; K J Tracey; P S Barie; K Manogue; A Cerami; G T Shires
Journal:  Surg Gynecol Obstet       Date:  1990-01

7.  Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanocortin mRNA during chronic inflammatory stress.

Authors:  M S Harbuz; R G Rees; D Eckland; D S Jessop; D Brewerton; S L Lightman
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

8.  Opioid peptides and primary biliary cirrhosis.

Authors:  J R Thornton; M S Losowsky
Journal:  BMJ       Date:  1988-12-10

9.  Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats.

Authors:  K Hashimoto; S Suemaru; T Takao; M Sugawara; S Makino; Z Ota
Journal:  Regul Pept       Date:  1988-11

10.  Corticotropin-releasing factor, but not arginine vasopressin, stimulates concentration-dependent increases in ACTH secretion from a single corticotrope. Implications for intracellular signals in stimulus-secretion coupling.

Authors:  B J Canny; L G Jia; D A Leong
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

View more
  13 in total

Review 1.  Fatigue in cholestatic liver disease--a perplexing symptom.

Authors:  D Kumar; R K Tandon
Journal:  Postgrad Med J       Date:  2002-07       Impact factor: 2.401

2.  Suppression of the HPA Axis During Cholestasis Can Be Attributed to Hypothalamic Bile Acid Signaling.

Authors:  Matthew McMillin; Gabriel Frampton; Matthew Quinn; Ali Divan; Stephanie Grant; Nisha Patel; Karen Newell-Rogers; Sharon DeMorrow
Journal:  Mol Endocrinol       Date:  2015-10-02

3.  Fluoxetine for the treatment of fatigue in primary biliary cirrhosis: a randomized, double-blind controlled trial.

Authors:  Jayant A Talwalkar; Jessica J Donlinger; Andrea A Gossard; Jill C Keach; Roberta A Jorgensen; Janice C Petz; Keith D Lindor
Journal:  Dig Dis Sci       Date:  2006-10-20       Impact factor: 3.199

4.  Suppression of the HPA axis during extrahepatic biliary obstruction induces cholangiocyte proliferation in the rat.

Authors:  Matthew Quinn; Yoshiyuki Ueno; Hae Yong Pae; Li Huang; Gabriel Frampton; Cheryl Galindo; Heather Francis; Darijana Horvat; Matthew McMillin; Sharon Demorrow
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-06       Impact factor: 4.052

5.  Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundice.

Authors:  Alison D McNeilly; David P Macfarlane; Emmett O'Flaherty; Dawn E Livingstone; Tijana Mitić; Kirsty M McConnell; Scott M McKenzie; Eleanor Davies; Rebecca M Reynolds; Helle C Thiesson; Ole Skøtt; Brian R Walker; Ruth Andrew
Journal:  J Hepatol       Date:  2010-03-04       Impact factor: 25.083

Review 6.  Effects of bile acids on neurological function and disease.

Authors:  Matthew McMillin; Sharon DeMorrow
Journal:  FASEB J       Date:  2016-07-28       Impact factor: 5.191

Review 7.  Fatigue in liver disease: pathophysiology and clinical management.

Authors:  Mark G Swain
Journal:  Can J Gastroenterol       Date:  2006-03       Impact factor: 3.522

8.  Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms.

Authors:  Matthew Quinn; Matthew McMillin; Cheryl Galindo; Gabriel Frampton; Hae Yong Pae; Sharon DeMorrow
Journal:  Dig Liver Dis       Date:  2014-03-12       Impact factor: 4.088

9.  Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.

Authors:  Suchun Li; Miaojuan Qiu; Yonglun Kong; Xiaoduo Zhao; Hyo-Jung Choi; Maria Reich; Brady H Bunkelman; Qiaojuan Liu; Shan Hu; Mengke Han; Haixia Xie; Avi Z Rosenberg; Verena Keitel; Tae-Hwan Kwon; Moshe Levi; Chunling Li; Weidong Wang
Journal:  J Am Soc Nephrol       Date:  2018-10-10       Impact factor: 10.121

10.  Glucocorticoids Cause Gender-Dependent Reversal of Hepatic Fibrosis in the MDR2-Knockout Mouse Model.

Authors:  Anca D Petrescu; Stephanie Grant; Gabriel Frampton; Jessica Kain; Karam Hadidi; Elaina Williams; Matthew McMillin; Sharon DeMorrow
Journal:  Int J Mol Sci       Date:  2017-11-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.